Author

Gemma Migneco

University of Leeds

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Organism:mouse· 1

Frequent Co-Authors

Alan A. MelcheriD· 1 shared Carolina S. IlkowiD· 1 shared Christy RalphiD· 1 shared David JacksoniD· 1 shared Fiona Errington‐MaisiD· 1 shared Graham P. CookiD· 1 shared Iain A. McNeishiD· 1 shared Isabelle St Hilare· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alan A. MelcherORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Enhancing oncolytic virotherapy by exosome-mediated microRNA reprograming of the tumour microenvironment.

Victoria A. Jennings, Reah Rumbold-Hall, Gemma Migneco, Tyler Barr, Katrina Reilly, Nicola Ingram, Isabelle St Hilare, Samuel Heaton, Noura Alzamel, David Jackson, Christy Ralph, Susana N. Banerjee, Iain A. McNeish, John Cameron Bell, Alan A. Melcher, , Fiona Errington‐Mais

This study uses oncolytic viruses to deliver miRNA to TAMs, reversing their immunosuppressive activity and improving ovarian cancer immunotherapy efficacy.

Frontiers in Immunology · Dec 23, 2024Peer-reviewedCancer Biology